Abatacept for GVHD Prophylaxis Reduces the Impact of Mismatching in Unrelated Donor Stem Cell Transplantation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation
Blood Adv 2022 Feb 08;6(3)746-749, M Qayed, B Watkins, S Gillespie, B Bratrude, K Betz, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, M Norkin, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, EK Waller, A Langston, LS Kean, JT HoranFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.